Lido Advisors
AMPH icon

Lido Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Lido Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,562
Closed -$220K – 1383
2023
Q4 		$220K Sell
3,562
-1,291
-27% -$67.8K ﹤0.01% 1175
2023
Q3 		$223K Sell
4,853
-1,706
-26% -$93.1K ﹤0.01% 1040
2023
Q2 		$377K Buy
+6,559
New +$291K ﹤0.01% 831
2022
Q2 		– Sell
-13,731
Closed -$492K – 931
2022
Q1 		$492K Buy
+13,731
New +$389K 0.01% 607

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Lido Advisors's AMPH Position: Q1 2024 in Review

Lido Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 3,562 shares — an estimated $220K sold.

Lido Advisors first reported a position in AMPH in Q1 2022 and held it in 4 quarters. The position peaked at $492K in Q1 2022. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • Lido Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Lido Advisors sold 3,562 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $220K.
  • Lido Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Lido Advisors's Amphastar Pharmaceuticals position peaked at $492K in Q1 2022.
  • 270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Lido Advisors's 13F filing for Q1 2024, filed 15 May 2024.